24. HELSINGIN YLIOPISTO – UH (FI)


 

24 logo

 

http://www.helsinki.fi/university

 

Principal Investigator: Dr. Qing Qiao

 

Brief description:

The University of Helsinki established in 1640, is the largest and most versatile university in Finland, and the top research university in Europe. It includes eleven faculties: Agriculture and Forestry, Arts, Behavioural Sciences, Biosciences, Law, Medicine, Pharmacy, Science, Social Sciences, Theology, and Veterinary Medicine. The University has ca. 35 000 students and 7 900 employees. The activities are located on four campuses.
High-level research is carried out at the departments of the faculties and departmentally affiliated research stations, as well as at independent research institutes.
Department of Public Health of the University of Helsinki (UH) is one of the leading research institutes in the field of epidemiology of T2D worldwide and very experienced in carrying out international collaborative research projects – these include the large collaborative DECODE and DECODA studies (Diabetes Epidemiology – Collaborative Analysis of Diagnostic Criteria in Europe/Asia) and the EU-funded DE-PLAN study. Studies of risk factors for T2D carried out by UH include both observational prospective studies and intervention trials, including the landmark Finnish Diabetes Prevention Study. In addition UH has a strong tradition of research into the genetics of T2D including the one of the largest genome-wide studies, FUSION (Finland-United States Investigation of Non-insulin dependent diabetes genetics). In general, UH has a very strong tradition in research into genetic epidemiology.

 

 

Main tasks attributed:

Will design and execute data management and analysis of lifestyle intervention and cost effectiveness, and report of the results in the current project.

 

Scroll to Top